{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:21:36Z","timestamp":1777411296209,"version":"3.51.4"},"reference-count":71,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/14656566.2026.2646283","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:09:01Z","timestamp":1774537741000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["An evaluation of cytisinicline for smoking cessation in adult smokers"],"prefix":"10.1080","volume":"27","author":[{"given":"Nancy A.","family":"Rigotti","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital","place":["Boston, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal L.","family":"Benowitz","sequence":"additional","affiliation":[{"name":"San Francisco General Hospital, University of California San Francisco","place":["San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"e_1_3_3_3_1","unstructured":"WHO. Report on the global tobacco epidemic 2025: warning about the dangers of tobacco. Geneva: World Health Organization; 2025 Jun 23. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240112063"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01169-7"},{"key":"e_1_3_3_5_1","unstructured":"National Center for Chronic Disease Prevention and Health Promotion (US). Office on smoking and Health. Atlanta (GA): The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General; 2014."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1211128"},{"key":"e_1_3_3_7_1","volume-title":"Smoking cessation: a report of the Surgeon General\u2014 Executive Summary","author":"U.S. Department of Health and Human Services","year":"2020","unstructured":"U.S. Department of Health and Human Services. Smoking cessation: a report of the Surgeon General\u2014 Executive Summary. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0395"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.23541"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2008.04.009"},{"key":"e_1_3_3_11_1","volume-title":"Who clinical treatment guideline for tobacco cessation in adults","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Who clinical treatment guideline for tobacco cessation in adults. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub5"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013308.pub2"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000031.pub5"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006103.pub8"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30272-0"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.10.027"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-1982ST"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-9-200111060-00012"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab209"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010216.pub10"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD016220.pub2"},{"key":"e_1_3_3_23_1","unstructured":"Nicotine pouch products authorized by the FDA | FDA. [cited 2026 Jan 23]."},{"key":"e_1_3_3_24_1","unstructured":"FDA authorized E-Cigarette products. FDA tobacco Education & Prevention Resources: posters flyers & more | FDA authorized E-Cigarette products. [cited 2026 Jan 23]."},{"key":"e_1_3_3_25_1","unstructured":"FDA Authorizes Marketing of Tobacco- and Menthol-Flavored JUUL E-Cigarette Products. FDA authorizes marketing of tobacco- and menthol-flavored JUUL E-Cigarette products. FDA; [cited 2026 Jan 23]."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14721"},{"issue":"6","key":"e_1_3_3_27_1","first-page":"777","article-title":"Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy","volume":"58","author":"Tutka P","year":"2006","unstructured":"Tutka P, Zatonski W. Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy. Pharmacol Rep. 2006;58(6):777\u2013798.","journal-title":"Pharmacol Rep"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.06.017"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/isci.2026.114874"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102035"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407764"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15489"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.7621"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.07.007"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16592"},{"key":"e_1_3_3_36_1","unstructured":"Achieve announces FDA acceptance of the investigational new Drug Application (IND) for Cytisine as a smoking cessation treatment | Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_37_1","unstructured":"Achieve reports financial results for Third Quarter 2018 and provides cytisinicline (cytisine) clinical development update | Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_38_1","unstructured":"Achieve Life Sciences announces submission of NDA to FDA for cytisinicline as a treatment of nicotine dependence for smoking cessation | Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_39_1","unstructured":"Achieve Life Sciences announces FDA acceptance of IND Application for cytisinicline\u2019s second planned indication for nicotine E-cigarette cessation | Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)03932-1"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpclett.2c02021"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntag039"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1707"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntab073"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.10042"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.0628"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-223880"},{"key":"e_1_3_3_48_1","volume-title":"Abstract presented at the annual meeting of the Society for Research in Nicotine and Tobacco","author":"Rigotti NA","year":"2026","unstructured":"Rigotti NA, Prochaska JJ, Benowitz NL, et al. Efficacy of cytisinicline for smoking cessation in adults with and without multiple prior quit attempts or prior pharmacotherapy use: pooled analysis of two Phase 3 trials. In: Abstract presented at the annual meeting of the Society for Research in Nicotine and Tobacco; Baltimore, MD; 2026 Mar 6."},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.56"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.47"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.64"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.110936"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015226.pub2"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.1313"},{"key":"e_1_3_3_55_1","unstructured":"Achieve Life Sciences to advance first vaping cessation therapy after successful end-of-Phase 2 meeting with FDA | Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105700"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntac233"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2018.1557760"},{"key":"e_1_3_3_59_1","unstructured":"Achieve Life Sciences meets key milestones advancing cytisinicline NDA for smoking cessation. Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_60_1","unstructured":"World Health Organization. Who expert committee on selection and use of essential medicines. A.8 Cytisine. A.8 Cytisine - smoking cessation. 25th [cited 2026 Jan 27]."},{"key":"e_1_3_3_61_1","unstructured":"Achieve Life Sciences announces FDA acceptance of cytisinicline New Drug Application for treatment of nicotine dependence for smoking cessation | Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_62_1","unstructured":"Achieve Life Sciences announces patent granted by USPTO for new cytisinicline formulation | Achieve Life Sciences; Achieve announces two patents granted by USPTO for novel cytisinicline dosing and administration regimen | Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_63_1","unstructured":"Achieve Life Sciences announces FDA grants breakthrough therapy designation to cytisinicline for the treatment of E-Cigarette or vaping nicotine dependence | Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_64_1","unstructured":"Achieve Life Sciences receives FDA Commissioner\u2019s National priority voucher for cytisinicline for treatment of nicotine dependence for E-cigarette or vaping cessation | Achieve Life Sciences. [cited 2026 Jan 24]."},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02919-2"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.3810"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7329a1"},{"key":"e_1_3_3_68_1","doi-asserted-by":"crossref","unstructured":"Livingston-Banks J Kale D Shahab L. Two of the best stop smoking medications have been available in the Uk since 2024 \u2013 so why is no one using them? The conversation. Published. 2025[cited 2026 Jan 24.","DOI":"10.64628\/AB.693h44u34"},{"key":"e_1_3_3_69_1","unstructured":"National Institute for Health and Care Excellence. Tobacco: preventing uptake promoting quitting and treating dependence (update). Evidence review Q for cytisinicline for smoking cessation NICE guideline NG209. 2025 Feb [cited 2026 Mar 6]. Available from: www.nice.org.uk\/guidance\/ng209"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.2471\/B09474"},{"key":"e_1_3_3_71_1","volume-title":"31st Society for Research on Nicotine and Tobacco Annual Meeting 2025","author":"Walker N","year":"2025","unstructured":"Walker N, Barnes J, Parag V, et al. Effectiveness, safety and acceptability of nicotine salt vapes, cytisine, and a combination of both products for smoking cessation: results from a New Zealand pragmatic community-based trial. In: 31st Society for Research on Nicotine and Tobacco Annual Meeting 2025; New Orleans (USA); 2025 Mar 12\u201315."},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13464"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2500685"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2026.2646283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:02:55Z","timestamp":1777017775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2026.2646283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/14656566.2026.2646283"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2026.2646283","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}